The Society of Critical Care Medicine recommended initiating insulin therapy when blood glucose levels reach 150 mg/dL (20), and an updated guideline suggested treating persistent hyperglycemia using a threshold of 180 mg/dL (39). The gene discussed is INS; the disease is Hyperglycemia.